THE BETA GROUP: Do Race Horses Have to be Killed for a Fractured Leg? sfbn.org/san-francisco-… #biotech #news

AbbVie puts $161M into new R&D site in Germany, will add 300 jobs sfbn.org/san-francisco-… #biotech #news

People with gas and propane stoves breathe more unhealthy nitrogen dioxide sfbn.org/san-francisco-… #biotech #news

Infectious disease DNA tester Karius nets $100M to expand liquid biopsy reach sfbn.org/san-francisco-… #biotech #news

Neuropsychiatry and sandwiches sfbn.org/san-francisco-… #news #biotech

Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up sfbn.org/san-francisco-… #news #biotech

Gilead cuts jobs, trims drugs amid deeper biopharma pullback sfbn.org/san-francisco-… #news #biotech

RevOpsis Welcomes Dr. Emmett Cunningham to Strategic Advisory Board sfbn.org/san-francisco-… #news #biotech

STAT+: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more sfbn.org/san-francisco-… #news #biotech

Chutes & Ladders—BridgeBio oncology execs take the reins of new spinout sfbn.org/san-francisco-… #biotech #news

Lykos Therapeutics Strengthens Commercial Organization with Key Hires as it Prepares for Potential Commercial Launch sfbn.org/san-francisco-… #biotech #news

Lonnel Coats announces retirement from Lexicon; Another shakeup in Vir’s C-suite sfbn.org/san-francisco-… #news #biotech

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock sfbn.org/san-francisco-… #biotech #news

California has set a cap on how much health care spending can rise per year. Here’s what you need to know. sfbn.org/san-francisco-… #biotech #news

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets sfbn.org/san-francisco-… #biotech #news

How Moderna’s cost-cutting moves hit a Bay Area biotech sfbn.org/san-francisco-… #biotech #news

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024 sfbn.org/san-francisco-… #biotech #news

Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results sfbn.org/san-francisco-… #biotech #news

Soleno Therapeutics Announces Proposed Public Offering of Common Stock sfbn.org/san-francisco-… #biotech #news

STAT+: Gilead gets a boost from California court in a case over slow-walking an HIV drug sfbn.org/san-francisco-… #biotech #news